We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Spinal Tap Needle Impacts Risk of Complications

By LabMedica International staff writers
Posted on 20 Dec 2017
A lumbar puncture, commonly known as a spinal tap, is a regular medical procedure used to diagnose and to treat disease. More...
Post-dural puncture headaches appear in about 35% of patients, sometimes causing debilitating pain that can lead to a return to hospital for painkillers or more invasive treatment.

Needle tip design has been proposed to affect the incidence of headache post-lumbar puncture, with pencil-point ‘atraumatic’ needles thought to reduce its incidence in comparison to beveled ‘traumatic’ needles. Despite this, the use of atraumatic needles and knowledge of their existence remains significantly limited among clinicians.

Medical scientists at McMaster University (Hamilton, ON, Canada) searched published randomized controlled trials (RCTs), observational studies and abstracts, with no publication type or language restrictions. They examined the outcomes of: headache and its type, intensity, duration and treatment; backache; success rate; hearing disturbance and nerve root irritation. The primary outcome was the incidence of post-dural puncture headache. The study pooled data from 110 clinical trials, with more than 30,000 participants in 29 countries across the past 28 years.

The team recorded that using atraumatic needles rather than conventional traumatic needles for lumbar punctures is just as effective and results in a significant decrease in complications such as the headaches, the need for intravenous fluid or controlled analgesia, nerve root irritation and hearing disturbance. They explained that the sharp edges of the tip of a conventional needle cuts its way through, while the tip of an atraumatic needle causes the tissue to dilate and contract around it. The tiny hole left in the dura by the atraumatic needle makes it significantly more difficult for cerebrospinal fluid to leak through, thus diminishing the frequency of headaches, readmissions and treatment. They also found the atraumatic needles cost the same or up to three times as much as the more conventional type.

Saleh A. Almenawer, MD, a neurosurgeon and senior author of the study, said, “There is a more than 50% reduction in the occurrence of headaches with the atraumatic needles, and also more than a 50% reduction in patient readmissions and return to emergency rooms for narcotics or blood patches. The two needles differ in how they penetrate the thick membrane, called the dura, surrounding the nerves. This study provides convincing high-quality evidence for people to change to the atraumatic needles for a better patient care.” The study was published on December 6, 2017, in the journal The Lancet.

Related Links:
McMaster University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.